Gene · 5345
Papers4,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Designing Smaller, Synthetic, Functional Mimetics of Sulfated Glycosaminoglycans as Allosteric Modulators of Coagulation Factors. | J Med Chem | 2023 | 37001055 | PubTator, text mining | PubMed |
| Approach to thromboelastography-based transfusion in cirrhosis: An alternative perspective on coagulation disorders. | World J Gastroenterol | 2023 | 36998429 | PubTator, text mining | PubMed |
| Viruses and amyloids - a vicious liaison. | Prion | 2023 | 36998202 | PubTator, text mining | PubMed |
| Adeno-associated virus 2 infection in children with non-A-E hepatitis. | Nature | 2023 | 36996873 | PubTator, text mining | PubMed |
| Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology. | PLoS One | 2023 | 36989283 | PubTator, text mining | PubMed |
| A Review of Quantitative Systems Pharmacology Models of the Coagulation Cascade: Opportunities for Improved Usability. | Pharmaceutics | 2023 | 36986779 | PubTator, text mining | PubMed |
| In Silico Study of Different Thrombolytic Agents for Fibrinolysis in Acute Ischemic Stroke. | Pharmaceutics | 2023 | 36986658 | PubTator, text mining | PubMed |
| Antileishmanial Activity of Cinnamic Acid Derivatives against Leishmania infantum. | Molecules | 2023 | 36985814 | PubTator, text mining | PubMed |
| Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity. | Int J Mol Sci | 2023 | 36982991 | PubTator, text mining | PubMed |
| Adipose-Derived Stem Cells in Reinforced Collagen Gel: A Comparison between Two Approaches to Differentiation towards Smooth Muscle Cells. | Int J Mol Sci | 2023 | 36982766 | PubTator, text mining | PubMed |
| Factor VII Activating Protease (FSAP) and Its Importance in Hemostasis-Part I: FSAP Structure, Synthesis and Activity Regulation: A Narrative Review. | Int J Mol Sci | 2023 | 36982544 | PubTator, text mining | PubMed |
| Novel Generation of FAP Inhibitor-Based Homodimers for Improved Application in Radiotheranostics. | Cancers (Basel) | 2023 | 36980775 | PubTator, text mining | PubMed |
| Prediction of Perforated and Nonperforated Acute Appendicitis Using Machine Learning-Based Explainable Artificial Intelligence. | Diagnostics (Basel) | 2023 | 36980481 | PubTator, text mining | PubMed |
| Proteomic Approaches and Potential Applications in Autosomal Dominant Polycystic Kidney Disease and Fabry Disease. | Diagnostics (Basel) | 2023 | 36980460 | PubTator, text mining | PubMed |
| Nanotechnology in Stroke: New Trails with Smaller Scales. | Biomedicines | 2023 | 36979759 | PubTator, text mining | PubMed |
| Effect of postoperative systemic prednisolone on short-term and long-term outcomes in chronic rhinosinusitis with nasal polyps: A multi-centered randomized clinical trial. | Front Immunol | 2023 | 36969262 | PubTator, text mining | PubMed |
| Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative. | Front Immunol | 2023 | 36969241 | PubTator, text mining | PubMed |
| Prevention strategies of postoperative adhesion in soft tissues by applying biomaterials: Based on the mechanisms of occurrence and development of adhesions. | Bioact Mater | 2023 | 36969107 | PubTator, text mining | PubMed |
| Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A role for viruses. | Blood Rev | 2023 | 36963989 | PubTator, text mining | PubMed |
| Fibrinolysis: an illustrated review. | Res Pract Thromb Haemost | 2023 | 36942151 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5345/papers?page=21